Covenant Asset Management’s Ligand Pharmaceuticals LGND Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Shares
Change %
Capital Flow Portfolio Weight Portfolio Position
2019
Q1
Sell
-16,630
Closed -$2.85M 136
2018
Q4
$2.85M Hold
16,630
1.43% 15
2018
Q3
$2.85M Sell
16,630
-64
-0.4% -$11K 1.43% 15
2018
Q2
$2.16M Buy
+16,694
New +$2.16M 1.17% 22